Interventional Cardiology Market is expected to reach US$ 28.67 billion by 2031 | Top key players - Medtronic Plc, Abbott, Johnson & Johnson.

Market Size and Forecast:

The Global Interventional Cardiology Market size reached US$ 14.47 billion in 2023 and is expected to reach US$ 28.67 billion by 2031, growing at a CAGR of 9.1% during the forecast period 2024-2031. The Market is driven by the rising prevalence of cardiovascular diseases and increasing adoption of minimally invasive procedures with advanced stent technologies. According to DataM Intelligence

To Download a Free Sample PDF (Use Corporate email ID to Get Higher Priority) at: https://datamintelligence.com/download-sample/interventional-cardiology-market?sz

The Interventional Cardiology Market encompasses minimally invasive procedures and devices used to diagnose and treat cardiovascular diseases, such as angioplasty, stenting, and structural heart interventions. It focuses on catheter-based techniques that improve blood flow, reduce heart complications, and enhance patient recovery outcomes, driving demand for advanced imaging, robotic systems, and innovative cardiovascular devices globally.

Industry Recent Developments: United States

✅ September 29, 2025: AngioSafe received FDA 510(k) clearance for its Santreva-ATK Endovascular Revascularization Catheter, a product designed to enhance minimally invasive procedures for peripheral vascular disease.

✅ September 8, 2025: The FDA granted 510(k) clearance for Microbot Medical's Endovascular Robotic System, marking a significant advancement in robotic-assisted interventions for peripheral vascular and endovascular aortic repair (EVAR).

✅ March 2025: Boston Scientific announced the acquisition of SoniVie Ltd. for approximately USD 360 million upfront to expand its portfolio with ultrasound-based renal denervation therapy for hypertension.

Industry Recent Developments: Japan

✅ September 2025: A major Japanese manufacturer launched a new robotic-assisted cardiac surgery system to improve precision and reduce operative time in coronary artery bypass grafting (CABG).

✅ August 2025: Terumo Corporation introduced a new version of its CAPIOX oxygenator with superior gas exchange capabilities and biocompatible coating for cardiac surgeries.

✅ July 2025: Fukuda started selling a line of minimally invasive cardiac surgical instruments for valve repair and replacement, addressing demand from Japan's aging population.

Get Customization in the report as per your requirements + Exclusive Bundle & Multi-User Discounts: https://datamintelligence.com/customize/interventional-cardiology-market?sz

FDA Approvals & Regulatory Actions (2025):

✅ Edwards Lifesciences - SAPIEN 3 TAVR platform: FDA granted an expanded indication to treat asymptomatic patients with severe aortic stenosis (Sapien 3 / Sapien 3 Ultra / Sapien 3 Ultra RESILIA). (May 1, 2025).

✅ Why it matters: first FDA approval of TAVR for asymptomatic severe AS - expands the population eligible for transcatheter therapy and is practice-changing for structural heart care.

✅ Verve Therapeutics - regulatory designation (drug development): The FDA awarded Fast Track designation to Verve's in-vivo base-editing program VERVE-102 (PCSK9 targeting) on April 11, 2025.
Why it matters: accelerates review pathways for a potential one-time gene-editing treatment aimed at durable LDL-C lowering (important for coronary risk reduction).

✅ Abbott - Navitor TAVI (Europe CE mark, 2025): Abbott obtained an expanded CE Mark for its Navitor transcatheter aortic valve system in 2025 (announced Aug 29, 2025) - included here because it's a major regulatory milestone in 2025 for structural heart devices and impacts global market dynamics.

Mergers & Acquisitions (2025):

✅ Eli Lilly → Verve Therapeutics: Lilly agreed to acquire Verve Therapeutics (deal announced June 17, 2025; closing/tender completion in Q3 2025), a high-profile buy (up to ~$1.3B) focused on Verve's PCSK9 base-editing program (VERVE-102). This ties gene-editing directly into major pharma cardiology strategies.

✅ Boston Scientific - Bolt Medical & SoniVie (2025): Boston Scientific announced purchases to broaden interventional cardiology / vascular offerings:

✅ Bolt Medical acquisition announced Jan 8, 2025 (to expand coronary/peripheral portfolio).

✅ SoniVie Ltd. agreement announced Mar 3, 2025 (ultrasound-based renal denervation tech - positioned as a treatment for hypertension with interventional implications).

Major Key Players:

Medtronic Plc
Abbott
Boston Scientific Corporation
Johnson & Johnson
B.Barun Melsungen
Biosensors International Ltd.
Terumo Corporation
Biotronik SE and Co KG
Edwards Lifesciences Corporation
Cook Medical Inc.

Segments Covered in the Interventional Cardiology Market:

By Type: Stents (Bare-Metal, Drug-eluting, Bio-absorbable), Catheters (Angioplasty, Guiding, Pulmonary Artery, IVUS), PTCA balloons (Normal, Cutting, Scoring, Drug-eluting), Image Systems (IVUS, FFR, OCT), laser Procedures, Atherectomy, Others.

By End User: Hospitals, Ambulatory Surgical Centres, Others.

Regional Analysis for Interventional Cardiology Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=interventional-cardiology-market

Chapter Outline:

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Interventional Cardiology market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Interventional Cardiology Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The global Interventional Cardiology market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Interventional Cardiology Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Frequently asked questions:

➠ What is the global sales value, production value, consumption value, import and export of Interventional Cardiology market?

➠ Who are the global key manufacturers of the Interventional Cardiology Industry? How is their operating situation (capacity, production, sales, price, cost, gross, and revenue)?

➠ What are the Interventional Cardiology market opportunities and threats faced by the vendors in the global Interventional Cardiology Industry?

➠ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?

➠ What focused approach and constraints are holding the Interventional Cardiology market?

➠ What are the different sales, marketing, and distribution channels in the global industry?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.